Exact Mass: 402.0861

Exact Mass Matches: 402.0861

Found 18 metabolites which its exact mass value is equals to given mass value 402.0861, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

4'-Phosphopantothenoylcysteine

(2R)-2-{3-[(2R)-2-hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanamido}-3-sulfanylpropanoic acid

C12H23N2O9PS (402.0862)


4-Phosphopantothenoylcysteine, also known as pantothenoylcysteine 4-phosphate, belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. 4-Phosphopantothenoylcysteine is an extremely weak basic (essentially neutral) compound (based on its pKa). Within humans, 4-phosphopantothenoylcysteine participates in a number of enzymatic reactions. In particular, cytidine monophosphate and 4-phosphopantothenoylcysteine can be biosynthesized from cytidine triphosphate, D-4-phosphopantothenate, and L-cysteine through the action of the enzyme phosphopantothenate--cysteine ligase. 4-Phosphopantothenoylcysteine (PPC) is an intermediate in the biosynthetic machinery (pathway) that converts pantothenate (vitamin B5) into coenzyme A (CoA). The enzyme phosphopantothenoylcysteine decarboxylase catalyzes the decarboxylation of PPC into 4-phosphopantetheine. Coenzyme A is the principal acyl carrier and is required for many synthetic and degradative reactions in intermediary metabolism, and is an essential cofactor in all living systems (PMID: 15450493, 16371361, 14501115). 4-Phosphopantothenoylcysteine (PPC) is an intermediate in the biosynthetic machinery (pathway) that converts pantothenate (vitamin B5) into coenzyme A (CoA). The enzyme Phosphopantothenoylcysteine decarboxylase catalyzes the decarboxylation of PPC to 4-phosphopantetheine. Coenzyme A is the principal acyl carrier and is required for many synthetic and degradative reactions in intermediary metabolism, and is an essential cofactor in all living systems. (PMID: 15450493, 16371361, 14501115) [HMDB]

   

Mollicellin J

Mollicellin J

C21H19ClO6 (402.087)


   

MCULE-9857824837

MCULE-9857824837

C21H19ClO6 (402.087)


   

Ethyl 2-cyano-3-[(2-ethoxy-2-oxoethyl)sulfanyl]-3-[2-(trifluoromethyl)anilino]acrylate

Ethyl 2-cyano-3-[(2-ethoxy-2-oxoethyl)sulfanyl]-3-[2-(trifluoromethyl)anilino]acrylate

C17H17F3N2O4S (402.0861)


   

MCULE-4495199001

MCULE-4495199001

C21H19ClO6 (402.087)


   

Pipoxide chlorohydrin

Pipoxide chlorohydrin

C21H19ClO6 (402.087)


   

C21H19ClO6_[5-(Benzoyloxy)-3-chloro-4,6-dihydroxy-1-cyclohexen-1-yl]methyl benzoate

NCGC00381300-01_C21H19ClO6_[5-(Benzoyloxy)-3-chloro-4,6-dihydroxy-1-cyclohexen-1-yl]methyl benzoate

C21H19ClO6 (402.087)


   

(5-benzoyloxy-3-chloro-4,6-dihydroxycyclohexen-1-yl)methyl benzoate

(5-benzoyloxy-3-chloro-4,6-dihydroxycyclohexen-1-yl)methyl benzoate

C21H19ClO6 (402.087)


   

(5-benzoyloxy-2-chloro-1,6-dihydroxycyclohex-3-en-1-yl)methyl benzoate

(5-benzoyloxy-2-chloro-1,6-dihydroxycyclohex-3-en-1-yl)methyl benzoate

C21H19ClO6 (402.087)


   

4-Phospho-N-pantothenoylcysteine

4-Phospho-N-pantothenoylcysteine

C12H23N2O9PS (402.0862)


   

Methicillin SodiuM

Methicillin SodiuM

C17H19N2NaO6S (402.0861)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

(1S,6alpha)-1-(Benzoyloxy)methyl-6-chloro-4-cyclohexene-1beta,2beta,3alpha-triol 3-benzoate

(1S,6alpha)-1-(Benzoyloxy)methyl-6-chloro-4-cyclohexene-1beta,2beta,3alpha-triol 3-benzoate

C21H19ClO6 (402.087)


   

N-[(R)-4-phosphopantothenoyl]-L-cysteine

N-[(R)-4-phosphopantothenoyl]-L-cysteine

C12H23N2O9PS (402.0862)


The N-[(R)-4-phosphopantothenoyl] derivative of L-cysteine.

   

Mollicellin J

Mollicellin J

C21H19ClO6 (402.087)


A member of the class of depsidones that is 11H-dibenzo[b,e][1,4]dioxepine substituted by a chloro group at position 2, hydroxy groups at position 3 and 7, methyl group at positions 1 and 9, a prenyl group at position 8, an oxo group at position 11 and a formyl group at position 4. Isolated from Chaetomium brasiliense it exhibits cytotoxic activity.

   

(2r)-2-[(3-{[(2r)-1,2-dihydroxy-3,3-dimethyl-4-(phosphonooxy)butylidene]amino}-1-hydroxypropylidene)amino]-3-sulfanylpropanoic acid

(2r)-2-[(3-{[(2r)-1,2-dihydroxy-3,3-dimethyl-4-(phosphonooxy)butylidene]amino}-1-hydroxypropylidene)amino]-3-sulfanylpropanoic acid

C12H23N2O9PS (402.0862)


   

2-chloro-7-[(1e)-hex-1-en-1-yl]-1,6,8-trihydroxy-3-methoxyanthracene-9,10-dione

2-chloro-7-[(1e)-hex-1-en-1-yl]-1,6,8-trihydroxy-3-methoxyanthracene-9,10-dione

C21H19ClO6 (402.087)


   

2-chloro-7-(hex-1-en-1-yl)-1,6,8-trihydroxy-3-methoxyanthracene-9,10-dione

2-chloro-7-(hex-1-en-1-yl)-1,6,8-trihydroxy-3-methoxyanthracene-9,10-dione

C21H19ClO6 (402.087)


   

(1r,4s,5s,6s)-5-[(benzoyloxy)methyl]-4-chloro-5,6-dihydroxycyclohex-2-en-1-yl benzoate

(1r,4s,5s,6s)-5-[(benzoyloxy)methyl]-4-chloro-5,6-dihydroxycyclohex-2-en-1-yl benzoate

C21H19ClO6 (402.087)